Cellebrite DI Ltd (NAS:CLBTW)
$ 5.25 (0%) Market Cap: 0 Enterprise Value: 0 PE Ratio: 49.21 PB Ratio: 6.73 GF Score: 84/100

Q1 2025 Cellebrite DI Ltd Earnings Call Transcript

May 14, 2025 / 12:30PM GMT

Key Points

Positve
  • Cellebrite DI Ltd (CLBT) reported a strong 23% year-on-year ARR growth in the first quarter of 2025.
  • The company achieved a 34% year-on-year growth in adjusted EBITDA, resulting in a 22% margin.
  • Cellebrite's Inseyets solution continues to gain traction, with over 30% of the install base converted and on track to hit a 50% conversion by 2025.
  • The Guardian product saw its third consecutive quarter of over 100% year-on-year ARR growth.
  • Cellebrite's global diversification and range of solutions across various sectors contributed to strong performance in the US state and local, Latin America, and Asia Pacific regions.
Negative
  • The US federal segment and EMEA geography experienced modest shortfalls, impacting overall performance.
  • The federal business environment remains volatile, with spending constraints affecting short-term performance.
  • Gross margins declined by 130 basis points year-over-year due to higher incremental costs for hosting and investments in customer success organizations.
  • Operating expenses increased by 13% year-over-year, driven by higher personnel costs and increased event and consulting expenses.
  • The company adjusted the low end of its full-year 2025 revenue guidance due to the timing of new business and lower one-time professional services revenue.
Operator

Welcome to the Cellebrite first quarter 2025 financial results conference call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for questions following the presentation. (Operator Instructions)

I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.

Andrew Kramer
Cellebrite DI Ltd - Vice President, Investor Relations

Thank you very much, Erica. Welcome everybody to Cellebrite's first quarter 2025 financial results call. I'm joined here today at our US headquarters outside of Washington, DC by our primary speakers: Tom Hogan, Cellebrite's Interim CEO, and Dana Gerner, Cellebrite's CFO. Joining us in person is Marcus Jewell, our CRO, and Ronnen Armon, our Chief Products and Technology Officer, is participating remotely. Marcus and Ronan will be available during Q&A.

There's a slide presentation that accompanies our prepared remarks. Please advance the slides in the webcast viewer to follow our commentary. We'll call out the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot